KM
NTUS

Kalos Management’s Natus Medical Inc NTUS Stock Holding History

Kalos Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,954
Closed -$338K – 157
2016
Q2 		$338K Buy
+8,954
New +$300K 0.26% 114

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Kalos Management's NTUS Position: Q3 2016 in Review

Kalos Management sold out of Natus Medical Inc (NTUS) in Q3 2016, closing a stake of 8,954 shares — an estimated $338K sold.

Kalos Management first reported a position in NTUS in Q2 2016 and held it in 1 quarter. The position peaked at $338K in Q2 2016. 196 funds tracked by Wall St. Rank hold NTUS as of Q3 2016.

  • Kalos Management reported no remaining Natus Medical Inc position as of Q3 2016 after selling out during the quarter.
  • Kalos Management sold 8,954 Natus Medical Inc shares in Q3 2016, an estimated $338K.
  • Kalos Management first reported a position in Natus Medical Inc in Q2 2016 and held it in 1 quarter.
  • Kalos Management's Natus Medical Inc position peaked at $338K in Q2 2016.
  • 196 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2016.

Based on Kalos Management's 13F filing for Q3 2016, filed 15 Nov 2016.